Paliperidón Teva (Paliperidone Palmitate)

Paliperidone palmitate, the active ingredient in Paliperidón Teva, is an antipsychotic presented as a long‑acting injectable suspension for intramuscular use. It is employed in the maintenance treatment of schizophrenia in adult patients. GNH USA supplies Paliperidón Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Paliperidón Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paliperidone palmitate is an atypical antipsychotic indicated for the treatment of schizophrenia, a chronic mental health disorder affecting thought, perception and behavior. - Schizophrenia: Reduces risk of relapse and helps maintain symptom control when administered as a monthly injection. - Schizoaffective disorder: Provides sustained symptom management over weeks to months. - Bipolar I disorder (maintenance): Contributes to mood stabilization and relapse prevention. - Adjunctive therapy: May be used alongside oral antipsychotics during transition to long‑acting therapy. - Preventive treatment of relapse in patients who prefer injection over daily oral medication. -  

The     ...  .... ... …  t

t  ....  .... ... ... ... ...